FRIDAY, DECEMBER 9, 2016

Universal quality-control standards sought for influenza vaccines

Scientists have been striving to counteract the misinformation surrounding influenza vaccines by improving their quality and developing a universal flu vaccine. Read More »

SIRION Biotech makes breakthrough in vaccine production

Scientists with SIRION Biotech recently reported that they have made significant progress with an innovative, breakthrough vaccine as novel production cell lines handle toxic antigens that are challenging to express. Read More »

PharmaSecure launches second phase of TB control program in India

PharmaSecure, a worldwide leader in providing customer engagement and brand protection solutions, recently launched the second phase of the “Grand Challenges in TB Control” grant program that is taking place in India. Read More »

SIRION Biotech plans new office in Boston region

SIRION Biotech, a top viral vector platform company that is renowned for developing high quality viral vector solutions for academic and industry partners, recently announce that it intends to established a new office within the area of Boston, Massachusetts. SIRION has partnered with the Massachusetts Life Sciences Center (MLSC) to find an office and lab space. Read More »

Third case, second death of EEE reported by New Hampshire DHHS

The third case of Eastern Equine Encephalitis (EEE) was reported on Wednesday by the New Hampshire Department of Health and Human Services (DHHS), representing the second death this season as a result of EEE in the state. Read More »